Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
- 31 December 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (4) , 431-435
- https://doi.org/10.1016/0277-5379(91)90379-r
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small‐cell lung carcinoma and neuroblastomaInternational Journal of Cancer, 1989
- Chapter 3 Results of the central data analysisLung Cancer, 1988
- Monoclonal antibody 123C3 in lung tumour classification Immunohistology of 358 resected lung tumoursMolecular and Cellular Probes, 1988
- The L2/HNK-1 carbohydrate of neural cell adhesion molecules is involved in cell interactions.The Journal of cell biology, 1988
- Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissuesInternational Journal of Cancer, 1988
- Monoclonal antibodies to polysialic acid reveal epitope sharing between invasive pathogenic bacteria, differentiating cells and tumor cellsImmunologic Research, 1987
- A new international staging system for lung cancerChest, 1986
- Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1Nature, 1984
- Quantification of the D2‐Glycoprotein in Amniotic Fluid and Serum from Pregnancies with Fetal Neural Tube DefectsJournal of Neurochemistry, 1983
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970